Financial results - GENASMEFA MED S.R.L.

Financial Summary - Genasmefa Med S.r.l.
Unique identification code: 40688104
Registration number: J2019000570266
Nace: 8622
Sales - Ron
71.496
Net Profit - Ron
21.123
Employees
3
Open Account
Company Genasmefa Med S.r.l. with Fiscal Code 40688104 recorded a turnover of 2024 of 71.496, with a net profit of 21.123 and having an average number of employees of 3. The company operates in the field of Activităţi de asistenţă medicală specializată having the NACE code 8622.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Genasmefa Med S.r.l.

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR - - - - 12.717 37.304 53.817 57.470 58.085 71.496
Total Income - EUR - - - - 12.717 37.346 53.821 57.470 58.087 71.503
Total Expenses - EUR - - - - 9.253 33.430 47.363 47.012 47.042 48.236
Gross Profit/Loss - EUR - - - - 3.464 3.916 6.458 10.457 11.045 23.268
Net Profit/Loss - EUR - - - - 3.336 3.550 5.919 9.902 10.464 21.123
Employees - - - - 1 3 3 3 2 3
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 23.8%, from 58.085 euro in the year 2023, to 71.496 euro in 2024. The Net Profit increased by 10.717 euro, from 10.464 euro in 2023, to 21.123 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Genasmefa Med S.r.l.

Rating financiar

Financial Rating -
GENASMEFA MED S.R.L.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Genasmefa Med S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Genasmefa Med S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Genasmefa Med S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Genasmefa Med S.r.l. - CUI 40688104

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets - - - - 93 69 47 26 1.058 2.330
Current Assets - - - - 4.254 8.275 15.560 17.881 19.590 20.669
Inventories - - - - 246 173 79 0 1.280 230
Receivables - - - - 3.642 3.542 6.918 2.566 11.385 7.131
Cash - - - - 367 4.560 8.563 15.315 6.925 13.308
Shareholders Funds - - - - 3.379 6.865 12.632 16.170 17.870 21.171
Social Capital - - - - 42 41 40 41 40 40
Debts - - - - 968 1.479 2.975 1.737 2.777 1.828
Income in Advance - - - - 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "8622 - 8622"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 20.669 euro in 2024 which includes Inventories of 230 euro, Receivables of 7.131 euro and cash availability of 13.308 euro.
The company's Equity was valued at 21.171 euro, while total Liabilities amounted to 1.828 euro. Equity increased by 3.400 euro, from 17.870 euro in 2023, to 21.171 in 2024.

Risk Reports Prices

Reviews - Genasmefa Med S.r.l.

Comments - Genasmefa Med S.r.l.

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.